Allergan Cuts A Few State Claims In Restasis MDL
Health benefits providers that refunded members for the cost of Allergan's dry-eye medication Restasis will be able to move forward on the majority of the state law claims the drugmaker wanted...To view the full article, register now.
Already a subscriber? Click here to view full article